Literature DB >> 4237065

Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

R W Colman, L Mattler, S Sherry.   

Abstract

Evidence is presented in this paper that the kaolin-activated arginine esterase of plasma is related to plasma kallikrein activity. Such a relationship is based on studies that (1) establish a constant ratio of esterase activity on various synthetic substrates for the kaolin-activated arginine esterase, purified kallikrein(s), and preparations obtained during the fractionation procedure; (2) exclude other known plasma and tissue arginine esterases; (3) confirm the requirement for factor XII in the activation of the enzyme precursor; and (4) show similarities in behavior between the plasma esterase and purified kallikrein(s) toward a variety of inhibitors. Based on this probable identification, evidence is provided that the concentration of active factor XII determines the rate of activation of plasma kallikreinogen, and that the activation may be blocked by polybrene. Once activated, plasma kallikrein is rapidly inactivated by the naturally occurring plasma inhibitor, but the inhibition is incomplete. Acid or chloroform treatment of plasma rapidly inactivates the plasma inhibitor without affecting the concentration of plasma kallikreinogen. Another plasma arginine esterase with properties suggestive of permeability factor is activated by factor XII in the presence of synthetic substrates, but only at low ionic strength. The data suggest that this enzyme is closely related to plasma kallikrein and that it arises from a common precursor.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4237065      PMCID: PMC322188          DOI: 10.1172/JCI105971

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  ASSAY OF UROKINASE PREPARATIONS WITH THE SYNTHETIC SUBSTRATE ACETYL-L-LYSINE METHYL ESTER.

Authors:  S SHERRY; N ALKJAERSIG; A P FLETCHER
Journal:  J Lab Clin Med       Date:  1964-07

2.  THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM.

Authors:  L J KAGEN; J P LEDDY; E L BECKER
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

3.  SOME BIOCHEMICAL AND PHYSICAL PROPERTIES OF THE HUMAN PERMEABILITY GLOBULINS.

Authors:  L J KAGEN
Journal:  Br J Exp Pathol       Date:  1964-12

4.  Relationship between air temperature and mean radiant temperature in thermal comfort.

Authors:  W KOCH
Journal:  Nature       Date:  1962-11-10       Impact factor: 49.962

5.  Action of the kallikreins on synthetic ester substrates.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Proc Soc Exp Biol Med       Date:  1961-05

6.  Partial purification of a serum inhibitor of C'1-esterase.

Authors:  J PENSKY; L R LEVY; I H LEPOW
Journal:  J Biol Chem       Date:  1961-06       Impact factor: 5.157

7.  The action of thrombin on synthetic substrates.

Authors:  S SHERRY; W TROLL
Journal:  J Biol Chem       Date:  1954-05       Impact factor: 5.157

8.  Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein.

Authors:  N S LANDERMAN; M E WEBSTER; E L BECKER; H E RATCLIFFE
Journal:  J Allergy       Date:  1962 Jul-Aug

9.  Plasma kinins and cortisol: a possible explanation of the anti-inflammatory action of cortisol.

Authors:  M J Cline; K L Melmon
Journal:  Science       Date:  1966-09-02       Impact factor: 47.728

10.  Observations on the spontaneous arginine and lysine esterase activity of human plasma, and their relation to Hageman factor.

Authors:  S Sherry; N K Alkjaersig; A P Fletcher
Journal:  Thromb Diath Haemorrh Suppl       Date:  1966
View more
  15 in total

1.  The profile of vascular permeability factors in dilute guinea-pig plasma.

Authors:  B Mason
Journal:  Br J Exp Pathol       Date:  1972-12

2.  Studies on the prekallikrein-bradykininogen system in liver disease.

Authors:  D Stewart; L M Blendis; R Williams
Journal:  J Clin Pathol       Date:  1972-05       Impact factor: 3.411

3.  Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.

Authors:  C F Scott; R W Colman
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

4.  Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.

Authors:  P Y Wong; R C Talamo; G H Williams; R W Colman
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

5.  Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization.

Authors:  H H Newball; R W Berninger; R C Talamo; L M Lichtenstein
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

6.  Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

Authors:  B H Petersen; J A Graham; G F Brooks
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

8.  Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.

Authors:  C Cordova; F Violi; C Alessandri; D Ferro; M Saliola; F Balsano
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

9.  Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate.

Authors:  C F Scott; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).

Authors:  C G Cochrane; K D Wuepper
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.